Jia‐Wei Lv

4.3k total citations
50 papers, 1.5k citations indexed

About

Jia‐Wei Lv is a scholar working on Molecular Biology, Otorhinolaryngology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jia‐Wei Lv has authored 50 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Otorhinolaryngology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jia‐Wei Lv's work include Head and Neck Cancer Studies (14 papers), Lung Cancer Treatments and Mutations (8 papers) and Cancer-related molecular mechanisms research (6 papers). Jia‐Wei Lv is often cited by papers focused on Head and Neck Cancer Studies (14 papers), Lung Cancer Treatments and Mutations (8 papers) and Cancer-related molecular mechanisms research (6 papers). Jia‐Wei Lv collaborates with scholars based in China, United States and India. Jia‐Wei Lv's co-authors include Guan‐Qun Zhou, Jun Ma, Ying Sun, Fo‐Ping Chen, Zi‐Qi Zheng, Li Lin, Xiaodan Huang, Xiaojun He, Zhi‐Xuan Li and Jia Kou and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Jia‐Wei Lv

46 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jia‐Wei Lv China 21 708 594 347 302 208 50 1.5k
Amritha Suresh India 24 544 0.8× 262 0.4× 349 1.0× 501 1.7× 153 0.7× 74 1.6k
Chih‐Jung Chen Taiwan 26 748 1.1× 554 0.9× 527 1.5× 73 0.2× 374 1.8× 113 2.0k
Madan Lal Brahma Bhatt India 20 556 0.8× 264 0.4× 259 0.7× 77 0.3× 147 0.7× 79 1.1k
Pei Yang China 16 497 0.7× 226 0.4× 192 0.6× 111 0.4× 105 0.5× 55 1.2k
Kam-Fai Lee Taiwan 22 401 0.6× 152 0.3× 169 0.5× 109 0.4× 217 1.0× 66 1.2k
Bahram Memar Iran 22 520 0.7× 285 0.5× 486 1.4× 50 0.2× 341 1.6× 87 1.4k
Chun‐Yi Chuang Taiwan 18 514 0.7× 221 0.4× 160 0.5× 113 0.4× 73 0.4× 56 963
Hongcheng Zhu China 27 929 1.3× 586 1.0× 527 1.5× 23 0.1× 333 1.6× 97 1.9k
Frank Schembri United States 12 970 1.4× 556 0.9× 148 0.4× 53 0.2× 87 0.4× 20 1.8k

Countries citing papers authored by Jia‐Wei Lv

Since Specialization
Citations

This map shows the geographic impact of Jia‐Wei Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jia‐Wei Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jia‐Wei Lv more than expected).

Fields of papers citing papers by Jia‐Wei Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jia‐Wei Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jia‐Wei Lv. The network helps show where Jia‐Wei Lv may publish in the future.

Co-authorship network of co-authors of Jia‐Wei Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Jia‐Wei Lv. A scholar is included among the top collaborators of Jia‐Wei Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jia‐Wei Lv. Jia‐Wei Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Yaqin, Xudong Xu, Peng Sun, et al.. (2024). KLF5 regulates actin remodeling to enhance the metastasis of nasopharyngeal carcinoma. Oncogene. 43(23). 1779–1795. 4 indexed citations
3.
Guo, Rui, Weiwei Zhang, Jia‐Wei Lv, et al.. (2024). Long-term Outcomes Following Individualized Primary Tumor Clinical Target Volume Delineation Based on Stepwise Spread Patterns of Nasopharyngeal Carcinoma Treated With Intensity-Modulated Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 122(1). 126–139.
4.
Long, Zhi‐Qing, Zi‐Qi Zheng, Lulu Zhang, et al.. (2023). m6A-enriched lncRNA LINC00839 promotes tumor progression by enhancing TAF15-mediated transcription of amine oxidase AOC1 in nasopharyngeal carcinoma. Journal of Biological Chemistry. 299(7). 104873–104873. 11 indexed citations
5.
Wei, Denghui, Jiayi Shen, Xiaoyu Liang, et al.. (2023). TEAD4 is a master regulator of high-risk nasopharyngeal carcinoma. Science Advances. 9(1). eadd0960–eadd0960. 21 indexed citations
6.
Chen, Zihang, Weihong Zheng, Chen‐Fei Wu, et al.. (2023). Thyroid dysfunction in Chinese nasopharyngeal carcinoma after anti-PD-1 therapy and its association with treatment response. BMC Medicine. 21(1). 18–18. 6 indexed citations
7.
Yang, Yuan, Bingyang Han, Jia‐Wei Lv, et al.. (2022). A Cost-Effective Way to Produce Gram-Scale 18O-Labeled Aromatic Aldehydes. Organic Letters. 24(24). 4409–4414. 8 indexed citations
8.
Lv, Jia‐Wei, et al.. (2022). Detecting Pests From Light-Trapping Images Based on Improved YOLOv3 Model and Instance Augmentation. Frontiers in Plant Science. 13. 939498–939498. 13 indexed citations
9.
Li, Wenyong, et al.. (2022). Detection of Small-Sized Insects in Sticky Trapping Images Using Spectral Residual Model and Machine Learning. Frontiers in Plant Science. 13. 915543–915543. 14 indexed citations
10.
Wu, Chen‐Fei, Li Lin, Yan‐Ping Mao, et al.. (2021). Liquid biopsy posttreatment surveillance in endemic nasopharyngeal carcinoma: a cost-effective strategy to integrate circulating cell-free Epstein-Barr virus DNA. BMC Medicine. 19(1). 193–193. 11 indexed citations
11.
Zheng, Zi‐Qi, Zhi‐Xuan Li, Xu Liu, et al.. (2020). Long Noncoding RNA TINCR-Mediated Regulation of Acetyl-CoA Metabolism Promotes Nasopharyngeal Carcinoma Progression and Chemoresistance. Cancer Research. 80(23). 5174–5188. 86 indexed citations
13.
Yang, Xing‐Li, Guan‐Qun Zhou, Li Lin, et al.. (2020). Prognostic value of radiation interruption in different periods for nasopharyngeal carcinoma patients in the intensity‐modulated radiation therapy era. Cancer Medicine. 10(1). 143–155. 4 indexed citations
14.
Zheng, Zi‐Qi, Zhi‐Xuan Li, Guan‐Qun Zhou, et al.. (2019). Long Noncoding RNA FAM225A Promotes Nasopharyngeal Carcinoma Tumorigenesis and Metastasis by Acting as ceRNA to Sponge miR-590-3p/miR-1275 and Upregulate ITGB3. Cancer Research. 79(18). 4612–4626. 279 indexed citations
15.
Lv, Jia‐Wei, Junyan Li, Linna Luo, Zixian Wang, & Yu‐Pei Chen. (2019). Comparative safety and efficacy of anti-PD-1 monotherapy, chemotherapy alone, and their combination therapy in advanced nasopharyngeal carcinoma: findings from recent advances in landmark trials. Journal for ImmunoTherapy of Cancer. 7(1). 159–159. 55 indexed citations
16.
Lv, Jia‐Wei, Yu‐Pei Chen, Guan‐Qun Zhou, et al.. (2019). Liquid biopsy tracking during sequential chemo-radiotherapy identifies distinct prognostic phenotypes in nasopharyngeal carcinoma. Nature Communications. 10(1). 3941–3941. 111 indexed citations
18.
Huang, Xiaodan, Guan‐Qun Zhou, Jia‐Wei Lv, et al.. (2018). Competing risk nomograms for nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data, intelligence platform-based analysis. Radiotherapy and Oncology. 129(2). 389–395. 39 indexed citations
20.
Lv, Jia‐Wei, Ying Wang, Rong Fan, et al.. (2015). Tamoxifen induces hepatotoxicity and changes to hepatocyte morphology at the early stage of endocrinotherapy in mice. Biomedical Reports. 4(1). 102–106. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026